Cardiff Oncology, Inc. financial data

Symbol
CRDF on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 456% % -20%
Debt-to-equity 28% % 26%
Return On Equity -82% % -11%
Return On Assets -64% % -5.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68,364,979 shares 2.8%
Common Stock, Shares, Outstanding 68,305,000 shares 2.7%
Entity Public Float $205,395,570 USD 107%
Common Stock, Value, Issued $7,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 66,841,000 shares 40%
Weighted Average Number of Shares Outstanding, Diluted 66,841,000 shares 40%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $593,000 USD -13%
Operating Income (Loss) $48,960,000 USD -0.64%
Nonoperating Income (Expense) $3,109,000 USD -3.4%
Net Income (Loss) Attributable to Parent $45,851,000 USD -0.92%
Earnings Per Share, Basic -0.69 USD/shares 27%
Earnings Per Share, Diluted -0.69 USD/shares 27%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $17,470,000 USD -66%
Cash, Cash Equivalents, and Short-term Investments $58,300,000 USD -36%
Accounts Receivable, after Allowance for Credit Loss, Current $182,000 USD -76%
Assets, Current $60,128,000 USD -37%
Property, Plant and Equipment, Net $578,000 USD -36%
Operating Lease, Right-of-Use Asset $629,000 USD -46%
Other Assets, Noncurrent $549,000 USD 696%
Assets $61,884,000 USD -36%
Accounts Payable, Current $8,087,000 USD 68%
Employee-related Liabilities, Current $2,430,000 USD -12%
Accrued Liabilities, Current $7,577,000 USD -4.1%
Liabilities, Current $16,394,000 USD 22%
Operating Lease, Liability, Noncurrent $102,000 USD -87%
Liabilities $16,496,000 USD 16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000 USD 47%
Retained Earnings (Accumulated Deficit) $430,030,000 USD -12%
Stockholders' Equity Attributable to Parent $45,388,000 USD -45%
Liabilities and Equity $61,884,000 USD -36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,794,000 USD -65%
Net Cash Provided by (Used in) Financing Activities $107,000 USD
Net Cash Provided by (Used in) Investing Activities $14,584,000 USD -415%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 68,305,000 shares 2.7%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $27,375,000 USD -813%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17,470,000 USD -66%
Deferred Tax Assets, Valuation Allowance $57,262,000 USD 18%
Deferred Tax Assets, Gross $57,398,000 USD 18%
Operating Lease, Liability $832,000 USD -45%
Depreciation $89,000 USD -12%
Payments to Acquire Property, Plant, and Equipment $80,000 USD 900%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $45,835,000 USD -1.1%
Lessee, Operating Lease, Liability, to be Paid $866,000 USD -47%
Property, Plant and Equipment, Gross $5,045,000 USD 0.2%
Operating Lease, Liability, Current $730,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $136,000 USD -83%
Lessee, Operating Lease, Liability, to be Paid, Year One $730,000 USD 2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $34,000 USD -71%
Lessee, Operating Lease, Liability, to be Paid, Year Three $136,000 USD -83%
Deferred Tax Assets, Operating Loss Carryforwards $31,977,000 USD 17%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $935,000 USD
Additional Paid in Capital $475,361,000 USD 1.8%
Depreciation, Depletion and Amortization $93,000 USD -8.8%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $5,693,000 USD 20%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%